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INTRODUCTION
Anaplasma phagocytophilum is an obligate intracellular 
gram-negative tick-borne rickettsiale bacterium of world-
wide distribution (Diniz and Breitschwerdt, 2012; Dumler 
et al., 2005; Woldehiwet, 2010). The bacterium is usually 
transmitted through the bites of ticks of Ixodes genera 
(Stuen et al., 2013; Swanson et al., 2006). This organism 
develops within intracytoplasmic inclusions in granulo-
cytic cells mainly neutrophils (Diniz and Breitschwerdt, 
2012; Dumler et al., 2005; Woldehiwet, 2010). A. phago-
cytophilum infects a wide variety of wild and domestic 
animals and causes an emerging zoonotic tick-borne 
disease called granulocytic anaplasmosis (Beugnet and 
Marié, 2009; Dumler et al., 2005; Keesing et al., 2014).
Tick-borne pathogens, a rising hazard in veterinary 
and human medicine
Vector-borne diseases (VBDs) are caused by various infec-
tious agents including parasites, bacteria and viruses that 
are transmitted to a host through the bite of hematophagous 
arthropods (Baneth, 2014; Beugnet and Marié, 2009; Hey-
man et al., 2010). A wide variety of VBDs affect both human 
and animals (Heyman et al., 2010). Ticks are considered to 
transmit the widest number of pathogens when compared 
to other arthropod vectors. Several of these pathogens are 
of veterinary and medical importance and cause various 
diseases including anaplasmosis, babesiosis, Lyme borrelio-
sis, ehrlichiosis and rickettsiosis (Baneth, 2014; Heyman et 
al., 2010; Nijhof et al., 2007). In geographic areas where 
mosquitos are not prevalent, TBDs are the primary causes 
of VBDs (Baneth, 2014; Michelet et al., 2014). VBDs and 
more specifically tick-borne diseases (TBDs) are a growing 
economic problem causing serious depression in livestock 
production worldwide (Heyman et al., 2010). Furthermore, 
canine VBDs have been of increased focus interest because 
they constitute an important threat to both canine and human 
health and are thus of major zoonotic relevance (Krämer et 
al., 2014; Rizzoli et al., 2014; Schreiber et al., 2014). Human 
is mostly not considered the main host target of tick-borne 
pathogens contrary to other vector-borne pathogens such as 
malaria or leishmaniasis, but an accidental host contaminated 
during the circulation between the vector and the wildlife host 
(Baneth, 2014; Michelet et al., 2014).  
Several VBDs are considered to be emerging in new re-
gions or re-emerging and changes in their epidemiological 
features are described including extension of geographi-
cal distribution, changes in pathogenicity and increased 
prevalence (Beugnet and Marié, 2009; Rizzoli et al., 2014; 
Swanson et al., 2006). Indeed, several TBDs have been 
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Résumé 
De nombreux agents vectoriels sont actuellement considérés comme émergents ou ré-émergents. Parmi ces organismes, 
Anaplasma phagcytophilum est une bactérie transmise par les tiques de distribution mondiale. Cette bactérie est de plus en 
plus détectées dans différents pays aussi bien chez le vecteur, la tique, et les hôtes constitués par les animaux et l’homme. A. 
phagocytophilum est responsable d’une maladie zoonotique, décrite chez différents animaux domestiques et chez l’homme, 
appelée ‘anaplasmose granulocytaire’. Actuellement, cette maladie est considérée comme la troisième plus importante maladie 
vectorielle en Europe et aux USA et est également de plus en plus rapportée en Asie. Toutefois, elle reste méconnue dans une 
large majorité de pays et aucunes données épidémiologiques n’y sont disponibles. 
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recently reported in previously not affected areas such 
as babesiosis in northern Germany, Belgium, Poland and 
the Netherlands, Candidatus Neoehrlichia mikurensis in 
central and northern Europe and Africa, canine monocytic 
ehrlichiosis is reported to extend from southern Europe to 
northern areas of France and described recently in Poland, 
Belgium and the Netherlands, tick-borne encephalitis virus 
is also extending to northern parts of Europe and granulo-
cytic anaplasmosis in northern Europe (Beugnet and Marié, 
2009; Day, 2011; Heyman et al., 2010; Krämer et al., 2014; 
Schreiber et al., 2014). 
Multiple factors are supposed to play a crucial role in ticks 
expansion, mainly increased animal travelling, climatic 
changes with global warming, landscape changes, reha-
bilitation and management with increased urbanization, 
development of large suburban areas with private gardens, 
creation of artificial lakes, deforestation and reforestation, 
increased open-air activities, changes in wild fauna, loss 
of biodiversity and decreased host population densities 
(Baneth, 2014; Day, 2011; Rymaszewska and Adamska, 
2011; Yancey et al., 2014). All these conditions affect the 
ecology and epidemiology of infectious diseases, enable the 
circulation, multiplication and spread of both vectors and 
pathogens into formerly unaffected areas, promote the cre-
ation of niches for vectors and the capacity to vector newly 
acquired pathogens, and also increase the risk for the host 
to enter in contact with vectors (Baneth, 2014; Day, 2011; 
Krämer et al., 2014; Yancey et al., 2014). 
The combination of urbanization, climate changes and 
landscape modification in urban and peri-urban areas cre-
ate favorable conditions to further increase ticks popula-
tions, extend areas of tick exposure for humans, promote 
the transmission of tick-borne pathogens and increases 
the number of human patients (Beugnet and Marié, 2009; 
Nicholson, 2010; Rizzoli et al., 2014). Beside these envi-
ronmental changes leading to increased hazard exposure 
to well-known vector-borne pathogens, increased clinician 
awareness, new diagnostic tools, improved surveillance 
and increased reporting and communication of tick-borne 
diseases in several countries can also explain the increased 
incidence of some tick-borne diseases (Baneth, 2014; Doud-
ier et al., 2010; Folkema et al., 2012; Heyman et al., 2010). 
Finally, advances in molecular biology allow the discovery 
of new species, strains or genetic variants and extend the list 
of microorganisms able to infect either animals or humans 
or both (Baneth, 2014; Doudier et al., 2010; Rizzoli et al., 
2014). Therefore, TBDs are increasingly recognized as ris-
ing hazard for public health (Rizzoli et al., 2014). These ob-
servations are particularly obvious for A. phagocytophilum. 
Indeed, the environment suitability of Ixodes scapularis 
and I. pacificus, the main vectors for B. burgdorferi and A. 
phagocytophilum, seems to increase in Canada (Villeneuve 
et al., 2011). Furthermore, high prevalences of A. phagocy-
tophilum in ticks have been recorded several in European 
countries (Rizzoli et al., 2014) and its prevalence is increas-
ing in both animals and humans (CDC, 2008; Folkema et 
al., 2012; Heikkilä et al., 2010). In the USA, both canine 
and human exposure has progressively increased from 2008 
to 2010 and from 2009 to 2010 respectively. The number 
of reported human cases has increased by 53% during this 
period (Qurollo et al., 2014). 
Description of the pathogen Anaplasma phagocytophilum
Anaplasma phagocytophilum is an obligate intracellular 
gram-negative tick-borne rickettsiale bacterium of 
worldwide distribution (Berzina et al., 2013; Diniz and 
Breitschwerdt, 2012; Dumler et al., 2005; Keesing et al., 
2014). The name of A. phagocytophilum has been given 
in 2001 to merge three previously distinct agents, the 
agent of equine granulocytic anaplasmosis or previously 
ehrlichiosis (E. equi), the agent of tick borne fever or pasture 
fever in sheep and cattle (E. phagocytophila) and the agent 
of human granulocytic anaplasmosis (previously human 
ehrlichiosis) (Dumler et al., 2001). 
This bacterium belongs to the family of Anaplasmataceae 
in the order of Rickettsiales (Alleman and Wamsley, 2008; 
Woldehiwet, 2010). The family Anaplasmataceae includes 
obligate intracellular arthropod-borne α-proteobacteria 
responsible of endemic and emerging diseases of major 
relevance in both veterinary and human medicine with 
important economic and public health outcomes (Pruneau 
et al., 2014). More specifically, Anaplasma and Ehrlichia 
genera include tick-borne pathogens that mostly infect 
peripheral blood cells (Dumler et al., 2005). Indeed, A. 
phagocytophilum infects myeloid cells of bone marrow, 
mainly neutrophils but also occasionnaly eosinophils. This 
organism develops within intracytoplasmic inclusions of 
varying size (from 1.5 to 6 mm in diameter) and derived 
from the host cell membrane called  “morula” (from Latin 
morum “mulberry”) (Figure 1) (Diniz and Breitschwerdt, 
2012; Dumler et al., 2005; Woldehiwet, 2010). 
A B
Figure 1: Morulae of A. phagocytophilum morula (black arrows) within a canine neutrophil, Wright’s stain, ×100 (A) (Carrade et al., 
2009) and in neutrophil of a 65-year-old man with a 2-day history of fever and diarrhea, Wright stain, ×100 (B) (Weil et al., 2012).
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A. phagocytophilum causes a zoonotic disease called 
granulocytic anaplasmosis (Beugnet and Marié, 2009; 
Dumler et al., 2005; Keesing et al., 2014). Before the 
mid 1990s and the discovery of the first cases of human 
granulocytic anaplasmosis (formerly human granulocytic 
ehrlichiosis) in Wisconsin, A. phagocytophilum was thought 
to infect only domestic animals and free-living reservoirs 
(Cochez et al., 2011; Dumler et al., 2005; Kybicová, 2010).
Epidemiological features of A. phagocytophilum
Geographic distribution
A. phagocytophilum infection in both people and domes-
tic animals has a worldwide geographic distribution that 
commonly follows the distribution of its vector, Ixodes 
spp ticks (Diniz and Breitschwerdt, 2012; Dumler et al., 
2007). Although A. phagocytophilum has been identified 
in several countries, the endemic areas include the upper 
Midwest, New England, western coast especially northern 
California, eastern and northeastern regions of the USA, 
British Colombia and some central and northern European 
countries (Sainz et al., 2015; Swanson et al., 2006; Kees-
ing et al., 2014). The organism has also been reported 
in Scandinavia, Baltic countries (Latvia, Lithuania, and 
Estonia), Finland, Asia, South America and North Africa 
(Berzina et al., 2013). However, data are lacking in large 
areas including parts of Asia, Africa, Latin America and 
Oceania (Swanson et al., 2006). In North Africa, only few 
data have been recently published in Tunisia, Algeria and 
Egypt (Azzag et al., 2015; Ben Said et al., 2014; Ghafar and 
Amer, 2012; M’ghirbi et al., 2009; M’ghirbi et al., 2012). 
Vector
A. phagocytophilum is defined as a tick-borne disease, 
contamination of people and domestic animal occurs 
mostly after tick bites especially when they come in 
contact with the vector in host reservoir habitat (Diniz 
and Breitschwerdt, 2012; Leiby et al., 2002). The 
bacterium is transmitted most frequently by ticks of Ixodes 
persulcatus complex (Stuen et al., 2013; Swanson et al., 
2006). Ticks included in this complex are involved in the 
transmission of the majority of Ixodes-vectored human 
diseases and the most important species are I. scapularis, 
I. pacificus, I. ricinus and I. persulcatus (Swanson et al., 
2006). These ticks have a worldwide distribution but are 
mainly encountered in the northern hemisphere (Figure 2) 
(Swanson et al., 2006; Woldehiwet, 2010).
Ixodes species involved in the transmission of the 
bacterium varies according to the geographic area (Figure 
2). In the United States, the main vectors are I. scapularis 
(blacklegged or deer tick) and I. pacificus (western-
blacklegged tick) (Figure 3) (Doudier et al., 2010; Jin et 
al., 2012). In Europe, especially in Northwestern areas, 
the most common vector is I. ricinus (sheep or castor 
bean tick) (Figure 3) (Jin et al., 2012; Swanson et al., 
2006). Some authors considered that this tick is the only 
vector of A. phagocytophilum in Europe (Heyman et 
al., 2010; Sainz et al., 2015). I. persulcatus tick (Figure 
3) is also present in some European regions especially 
eastern parts, and can share some areas with I. ricinus 
(Figure 2). This tick species has a geographic area that 
extends into Japan and is considered the primary vector 
in Asia (Sainz et al., 2015; Swanson et al., 2006). In 
eastern Mediterranean areas and North Africa, ticks of 
Rhipicephalus, Hyalomma, and Haemaphysalis genera 
are also involved in the transmission of the bacterium 
(Ghafar and Amer, 2012; Qablan et al., 2012; M’ghirbi et 
al., 2012; Sarih et al., 2005). A wide variety of other tick 
species were found to be positive to A. phagocytophilum 
in the USA, Europe and Asia including other Ixodes spp., 
Amblyomma americanum, Dermacentor spp., (Doudier et 
al., 2010; Jin et al., 2012; Stuen et al., 2013). 
Figure 2: Worldwide geographic distributions of Ixodes tick species, vectors of A. phagocytophilum 
(Adapted from Swanson et al. 2006)
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Ixodes scapularis
Blacklegged tick
Deer tick
Ixodes pacificus
Western-blacklegged tick
Ixodes ricinus
Sheep tick 
Castor bean tick
Ixodes persulcatus
         
Rhipicephalus sanguineus
   Male    Female
Figure 3: Ticks involved in the transmission of A. phagocytophilum in the USA, Europe, Asia and the Mediterranean region. I. 
scapularis I. pacificus, R. sanguineus (TickEncounter Resource Center of the University of Rhode Island), I. ricinus (Stanek et 
al. 2012 ), tick developmental stages and I. persulcatus (Online photographic guide to ticks, Bristol University tick ID).
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Reservoir hosts
The absence of transovarian transmission in the vector 
makes it unable to act as a reservoir of A. phagocytophilum. 
Although a wide range of animal species can be infected 
by the bacterium, hosts might fulfill several characteristics 
to be considered as competent reservoir. Indeed, a host 
reservoir must be fed on by an infected vector tick at least 
occasionally, take up a critical number of the infectious 
agent during the bite by an infected tick, allow the 
pathogen to multiply and survive for a period in at least 
some parts of his body and might allow the pathogen to find 
its way into other feeding ticks (Rizzoli et al., 2014; Stuen 
et al., 2013). Several mammalian species are considered 
as host reservoir and thus, enable the persistence of the 
bacterium between seasons of tick activity and its spread 
through their movement in case of migratory animals 
(Stuen et al., 2013). Among them, rodents and wild cervids 
are considered to be the principal host reservoir of the 
bacterium (Alleman and Wamsley, 2008; Beugnet and 
Marié, 2009; Nicholson et al., 2010). 
In Europe, even though A. phagocytophilum has been 
detected in a wide range of wild animal species, the 
reservoir host for the human pathogenic strain is still 
unknown (Heyman et al., 2010; Michalik et al., 2012; 
Strasek Smrdel et al., 2015). Indeed, the reservoir 
competence of rodents is not established and cervids are 
reported to disseminate mainly variants that have not 
been isolated in humans with possible exception for red 
deer (Michalik et al., 2012). Similarly, no information is 
available on the reservoir hots competence of wild animals 
for A. phagocytophilum in Asia (Cao et al., 2006). Only 
few studies have been carried and showed relatively high 
prevalence rates of infection by A. phagocytophilum in 
wild ruminants and small mammals (Stuen et al., 2013). 
A. phagocytophilum has been also detected in several other 
wild vertebrates including boar, fox, bear, European bison, 
donkey, moose, hare, Eurasian lynx, birds and reptiles 
(Kybicovà, 2010; Stuen et al., 2013). However, their role 
in the bacterium life cycle is not assessed (Stuen et al., 
2013). In some geographical areas, several bird species 
are thought to be either competent host reservoirs of the 
bacterium or to contribute to the circulation and spread 
of infected ticks (Diniz and Breitschwerdt, 2012; Little, 
2012; Woldehiwet, 2010). 
Life cycle of A. phagocytophilum transmission by 
Ixodes tick species
A. phagocytophilum is considered to be naturally 
maintained in a tick-rodent cycle (Figure 4) (Cao et al., 
2006). The interaction between reservoir hosts and tick-
borne pathogens is variable and has a direct impact on 
transmission dynamics. In the case of bacterial tick-borne 
infections that often lead to an immune system response in 
the host reservoir or to its death limiting the bacteriaemic 
phase, ticks represent a critical feature for the maintenance 
of the enzootic cycle in nature. The perpetuation of cycles 
can be ensured either by the transmission of the pathogens 
between different tick development stages (transstadial 
transmission), or between generation (transovarian 
transmission) or between ticks during cofeeding (Swanson 
et al., 2006).  
The life cycle of Ixodes ticks lasts for almost 2 years 
(Littman et al., 2006; Swanson et al., 2006) and its 
duration depends on climatic conditions varying from less 
than a year in tropical regions to three or more years in 
temperate regions (Heyman et al., 2010). This life cycle 
comprises four distinct developmental stages: egg, larva, 
nymph and adult. Ixodes ticks activity varies according 
to the life stage and they mostly quest on vegetation in 
prime suburban real estate (Littman et al., 2006; Swanson 
et al., 2006). The feeding behavior at each life stage 
has a directly effect on the risk of tick-borne pathogens 
transmission (Swanson et al., 2006). All Ixodes species of 
public health relevance need to feed on a new host at each 
life stage after hatching and the blood meal is completed 
in three to five days (Heyman et al., 2010; Swanson et 
al., 2006). Ticks belonging to I. persulcatus complex are 
exophilic, anthropophilic and nonspecific feeding ticks. 
Consequently, they can have their blood meal on both 
various host reservoirs and on humans (Stuen et al., 2013; 
Swanson et al., 2006).  
A. phagocytophilum is transmitted to the host during the 
bite of a nymphal or adult tick infected during previous 
stages (larval or nymphal) (Diniz and Breitschwerdt, 
2012; Doudier et al., 2010; Nicholson et al., 2010) 
(Figure 4). Transmission of A. phagocytophilum to the 
host during tick feeding occurs usually within 24 to 48 
h. Consequently, at least daily removal of ticks should be 
recommended in association with ectoparasites preventive 
treatment in endemic areas to avoid the transmission of the 
bacterium (Cockwill et al., 2009). As nymphs have very 
small size (approximately 1 mm), they are often able to 
feed much longer and are at increased risk to transmit tick-
borne pathogens such as A. phagocytophilum (Heyman et 
al., 2010; Swanson et al., 2006). In contrast, adult ticks are 
bigger making them more quickly detectable and removed 
before disease transmission (Swanson et al., 2006). Due 
to the transstadial transmission, nymphs and adult ticks 
contaminated in a previous stage last infected after molting 
and are able to contanimate susceptible hosts during the 
following blood meals. 
Adult female ticks require an additional feeding to devolop 
their egg (Heyman et al., 2010; Swanson et al., 2006). This 
additional blood meal could explain the higher prevalence 
of A. phagocytophilum in adult ticks reported in some 
studies (Stuen et al., 2013). As A. phagocytophilum is not 
transmitted transovarially among Ixodes ticks (Dumler 
et al., 2005; Stuen et al., 2013; Swanson et al., 2006), 
larvae are mostly considered free from infection until 
hatching and having their first blood meal (Doudier et al., 
2010; Swanson et al., 2006). Another consequence of the 
absence of transovarial transmission is that when adult 
femal tick laid their eggs, the bacterial cycle is interrupted 
(Bakken and Dumler, 2008; Stuen et al., 2013).
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Figure 4. Life cycle of A. phagocytophilum (Diniz and 
Breitschwerdt, 2012). The perpetuation of the bacterium in 
nature is ensured through the transmission from competent 
reservoir hosts (small mammals and/or wild cervids) to the tick 
vector. Incidental transmission to other hosts including domestic 
carnivores and humans is also possible after tick bite.
A. phagocytophilum a zoonotic pathogen of veteri-
nary and public health importance
A large variety of mammals are receptive to A. 
phagocytophilum. However, the disease has been 
described only in dogs, horses, cattle, sheep, goats, llamas, 
cats and humans (Eberts et al., 2011; Gorna et al., 2013; 
Mazepa et al., 2010). People and domestic animals are 
considered incidental hosts (Poitout et al., 2005).
In domestic ruminants 
A. phagocytophilum was first described in domestic ru-
minants including sheep, goat, deer and cattle (Carrade et 
al., 2009; Jin et al., 2012; Woldehiwet, 2010). The disease 
was named tick-borne fever (TBF) in ruminants and was 
first described in sheep in Scotland in 1932 (Cochez et al., 
2011; Jin et al., 2012). Later in the 1950s, the bacterium 
was identified as the causative agent of pasture fever in 
cattle in England (Beugnet and Marié, 2009). Then, A. 
phagocytophilum has been reported in sheep and cattle 
with TBF in several countries of Europe including Ireland, 
Scandinavia, Netherlands, Austria, Switzerland and Spain 
(Beugnet and Marié, 2009; Woldehiwet, 2010). Recently, 
the organism has also been identified in camelids (Ben Said 
et al., 2014; Carrade et al., 2009; Mentaberre et al., 2013).
Two recent studies that investigated the prevalence of A. 
phagocytophilum in Tunisia and Canaries Islands found a 
prevalence of 29.2 and 3% respectively (Ben Said et al., 
2014; Mentaberre et al., 2013). The disease, also called 
bovine ehrlichiosis, is mostly described in spring and 
autumn in animals grazing in favorable biotopes for ticks 
(Guyot et al., 2011). Clinical signs associated with TBF 
and pasture fever include a sudden onset of high fever, 
anorexia, dullness, arthritis, oedema of legs and weight 
loss. Less frequently, cutaneous and mucous membrane 
hemorrhage were also described (Ben Said et al., 2014; 
Guyot et al., 2011; Stuen et al., 2013). 
A. phagocytophilum infection can also induce immune 
deficiency in ruminants (Ben Said et al., 2013; Guyot et 
al., 2011) leading to secondary opportunistic infections 
such as Staphylococcus aureus, Pasteurella spp. and 
Listeria monocytogenes infections (Carrade et al., 2009). 
The severity of fever varies according to the age of the 
animal, the variant involved, the host species and the 
immunological status of the individual affected. Young 
animals and tick-free individuals placed on infested pas-
ture seem to be the most sensitive to A. phagocytophilum 
infection (Stuen et al., 2013).  In addition, the disease is 
considered to be a cause of important productivity loss in 
dairy cattle including drop in milk yield, reduced weight 
gain in infected bullocks and lambs, reduced fertility and 
abortions (Ben Said et al., 2014; Beugnet and Marié, 2009; 
Stuen et al., 2013).  
In horses
The disease was initially known as equine granulocytic 
ehrlichiosis (EGE) and was first reported in California in 
the late 1960s (M’ghirbi et al., 2012; Pusterla and Madigan, 
2013). Other cases were then described in several parts of 
Europe and America including Scandinavia, Switzerland, 
the United Kingdom, France, Brazil, Canada, Florida, Wash-
ington, Oregon, New York, Colorado, Illinois, Minnesota, 
Indiana, Wisconsin, New Jersey and Connecticut (Beugnet 
and Marié, 2009; Pusterla and Madigan, 2013; Woldehiwet, 
2010). In Europe, the seroreactivity to A. phagocytophilum 
in horses has been assessed in several countries and varies 
from 6.52 to 22.3% (M’ghirbi et al., 2012). 
A recent study carried out on 60 horses living in regions fa-
vorable to I. ricinus tick in Tunisia revealed a prevalence of 
67 and 13% by serology and PCR respectively. The preva-
lence by PCR is similar to reported rates in Italy (M’ghirbi 
et al., 2012). Equine granulocytic anaplasmosis is described 
as an acute disease with an estimated incubation period of 
less than two weeks. The disease in mainly characterized 
by fever, lethargy, inappetence, staggering or ataxia, distal 
limb edema, reluctance to move and icterus (Franzen et al., 
2009; M’ghirbi et al., 2012; Pusterla and Madigan, 2013). 
Occasionally, cardiac arrhythmia is reported including ven-
tricular tachycardia and premature ventricular contractions 
and are possibly due to myocardial vasculitis (Pusterla and 
Madigan, 2013). Clinical presentation is unspecific like in 
other animal species and mimics other infectious diseases 
including Lyme disease, leptospirosis, babesiosis, theile-
riosis, equine herpes virus and equine infectious anemia 
virus (M’ghirbi et al., 2012). These clinical signs can also 
be associated with hematological modifications including 
thrombocytopenia, leucopenia, neutropenia, lymphopenia 
and mild anemia. The evolution is mostly favorable, even 
without treatment, with recovery several weeks after the 
onset of symptoms (Franzen et al., 2009; M’ghirbi et al., 
2012; Pusterla and Madigan, 2013). Indeed, subclinical 
infections are estimated to reach up to 50% of equine 
cases and thus the disease seems largely underestimated in 
most endemic European countries (M’ghirbi et al., 2012). 
However, fatalities exist and can be due to opportunistic 
infections or traumatic injuries secondary to the lack of 
coordination (Pusterla and Madigan, 2013). 
The severity of the diseases varies according to the age 
with horses less than 1 year old displaying limited clinical 
signs, those younger than 4 years old developing mild 
clinical signs and those older than 4 years old develop 
progressive characteristic disease (Pusterla and Madigan, 
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2013). The duration of the disease varies from 3 to 16 
days. During natural infection, the peak of antibody titer 
occurs 19 to 81 days after the onset of clinical signs. 
Immunity seems to be protective and lasts for at least 2 
years (M’ghirbi et al., 2012; Pusterla and Madigan, 2013). 
In experimentally infected horses, antibody titer starts 
to progressively decline 300 days post-infection unless 
reinfection occurs (M’ghirbi et al., 2012).
In companion animals (cats and dogs)
A. phagocytophilum infection was recognized for the 
first time in dogs in 1982 in California (Little, 2012; 
Woldehiwet, 2010). The disease has been described in 
several states of the USA but also in Europe as soon as 
the late 1980s (Beugnet and Marié, 2009; Carrade et al., 
2009). Most dogs infected by A. phagocytophilum remain 
apparently healthy. This is suggested by the discrepancy 
between the high seroprevalence and the relative low 
number of sick dogs in endemic areas (Carrade et al., 2009; 
Diniz and Breitschwerdt, 2012; Ravnick et al., 2014). 
Therefore, most immuno-competent dogs seem to control 
this infection and thus develop a subclinical or mild and 
self-limiting disease (Diniz and Breitschwerdt, 2012). 
However, some dogs infected by A. phagocytophilum 
develop an unspecific illness mostly characterized by 
an acute onset of fever, lethargy, depression, decreased 
appetite or anorexia, weight loss and musculoskeletal pain 
or discomfort (Beugnet and Marié, 2009; Carrade et al., 
2009; Diniz and Breitschwerdt, 2012). Lymphadenopathy, 
splenomegaly and hepatomegaly are also frequently 
described (Diniz and Breitschwerdt, 2012; Little, 2012). 
Less frequent clinical signs include digestive signs, 
polyuria, polydipsia, respiratory signs, pale mucous 
membranes, hemorrhagic diathesis, collapse, uveitis, 
scleral congestion, endocarditis, polymyositis and 
neurological signs (Carrade et al., 2009; Cockwill et al., 
2009; Diniz and Breitschwerdt, 2012; Mazepa et al., 2010; 
Ravnik et al., 2011; Silaghi et al., 2011). 
Most important hematological and serum biochemistry 
profile modifications associated with canine granulocytic 
anaplasmosis include thrombocytopenia, mild to moderate 
nonregenerative normocytic normochromic and increased 
liver enzymes activity (Carrade et al., 2009; Diniz and 
Breitschwerdt, 2012; Kohn et al., 2008; Silaghi et al., 
2011). The severity of the disease is variable, from a 
subclinical infection to an acute form with severe clinical 
presentation (Poitout et al., 2005; Ravnik et al., 2011). The 
variability of the severity of clinical signs can be due either 
to the presence of co-infections, the immune response of 
the host or the virulence of strains/variants (Carrade et al., 
2009; Diniz and Breitschwerdt, 2012; Mazepa et al., 2010). 
The prognosis of the disease in dogs is usually favorable 
with a rapid remission after doxycycline therapy (Mazepa 
et al., 2010; Ravnick et al., 2014). However, few fatality 
cases are reported (Bexfield et al., 2005; Kohn et al., 2008; 
Mazepa et al., 2010). 
More recent experimental studies have shown that cats are 
also susceptible to the infection by A. phagocytophilum. 
The first case in feline species was reported in the late 
1990s (Beugnet and Marié, 2009; Lappin et al., 2012; 
Little, 2012). Then only few reports described feline 
cases of granulocytic anaplasmosis in European countries 
including Sweden, Switzerland, Finland and Italy (Gorna 
et al., 2013). Even though granulocytic anaplasmosis is 
increasingly diagnosed all over the world, the disease seems 
to be rarely identified among cats. This can be due to their 
particular behavior that can remove ticks during grooming 
or to differences in the pathogenesis of the disease in this 
species (Gorna et al. 2013; Heikkilä et al., 2010). 
In cats, the bacterium causes clinical signs similar to 
those described in dogs including fever, lameness, 
enlarged lymph nodes, lethargy, tachypnoea, anorexia and 
weight loss (Heikkilä et al., 2010; Lappin et al., 2012; 
Little, 2012). Periodontal disease, gingivitis, vomiting, 
abdominal pain, pharyngitis, polydipsia, hematuria, 
muscle and joint pain, conjunctivitis and neurologic 
signs including hyperesthesia, tremors, incoordination 
and shyness have also been reported (Gorna et al., 
2013; Heikkilä et al., 2010; Little, 2012). However, 
whether these symptoms are attributed to anaplasmosis 
or to opportunistic infections secondary to an immune 
deficiency associated with A. phagocytophilum infection 
is unknown (Heikkilä et al., 2010). Like in dogs, these 
clinical signs are often accompanied by hematological and 
biochemical abnormalities including thrombocytopenia, 
lymphopenia, neutrophilia with a left shift, anemia, 
monoclonal gammopathy, and increased liver enzymes 
activity (Gorna et al., 2013; Heikkilä et al., 2010; Lappin 
et al., 2012). Thrombocytopenia is the most common 
hematological abnormality like described in other species 
and is mild to moderate in cats (Heikkilä et al., 2010). 
In humans
Currently, human granulocytic anaplasmosis (HGA) is 
considered to be the third most important vector-borne 
disease in both the USA and Europe and is also increasingly 
diagnosed in some Asian countries (Dumler, 2012; Li et 
al., 2011; Zhang et al., 2008). In the USA, anaplasmosis 
is a nationally notifiable disease (Bakken and Dumler, 
2008; CDC, 2008) and the number of cases has critically 
and rapidly increased (Figure 5). Between 2000 and 2010, 
incidence has increased from 1.4 to 6.1 cases per million 
inhabitants (Dahlgren et al., 2011; Rizzoli et al., 2014).
Figure 5: Number of annual human granulocytic anaplas-
mosis cases in the USA from 1994 to 2010  (http://www.cdc.
gov/anaplasmosis/stats/)
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HGA is an unspecific flu-like illness mostly character-
ized by fever, headache, chills, myalgia and malaise 
(Dumler, 2012; Folkema et al., 2012; Rymaszewska and 
Adamska, 2011). Symptoms usually appear ten days to 
three weeks after tick bite (Heyman et al., 2010; Stuen 
et al., 2013). In most cases, clinical signs are mild and 
self-limited, with favorable evolution even without 
treament (Cochez et al., 2011; Jin et al., 2012). How-
ever, some patients can develop severe life-threatening 
complications (Cochez et al., 2011; Dumler, 2012; Jin et 
al., 2012). Due to the potential serious outcomes associ-
ated with the disease, the Infectious diseases Society 
of America recommends to give antimicrobial therapy 
to every person suspected to have HGA on the basis 
of clinical presentation although mild or self-limiting 
pending the laboratory results and to do not delay the 
treatment (Heyman et al., 2010). 
CONCLUSION
Although A. phagocytophilum is known as a veterinary 
pathogen causing disease in ruminants since more than 70 
years, its zoonotic potential is more recently recognized. 
The ability of causing disease in humans with potential 
severe outcomes, the worldwide distribution and the rising 
focus on ticks and tick-borne diseases increased physician 
interest and awareness on this emerging pathogen. The 
difficulty of diagnosis either in human or in veterinary 
medicine and the importance of giving early treatment to 
avoid severe complications highlight the importance of 
improved knowledge on this pathogen especially epidemi-
ological information. Epidemiological data are also cru-
cial to perform effective preventive strategies. Although 
the number of publications on A. phagocytophilum and 
granulocytic anaplasmosis is important and increasing, 
several data are still missing including epidemiological 
informations in huge parts of Asia, Latin America and 
Africa and implications of strain variability in the patho-
genicity of the disease. Several works on this pathogen 
are ongoing in Morocco in ruminants, dogs, ticks and 
humans in order to elucidate mechanisms of transmission 
and epidemiological context on this infection.
REFERENCES
Alleman A.R. and Wamsley H.L. (2008). An update on 
anaplasmosis in dogs. Vet. Med. 103: 212-220.
Azzag N., Petit E., Gandoin C., Bouillin  C., Ghalmi F., 
Haddad N. and Bouloui A.J. (2015). Prevalence of 
select vector-borne pathogens in stray and client-
owned dogs from Algiers. Comp. Immunol. Microbiol. 
Infect. Dis. 38: 1-7.
Bakken J.S. and Dumler S. (2008). Human granulocytic 
anaplasmosis. Infect. Dis. Clin. North Am. 22: 433-
448.
Baneth G. (2014). Tick-born infections of animals and 
humans: a common ground. Int. J. Parasitol. 44: 
591-596.
Ben Said M., Belkahia H., Sayahi L., Aloui M., Jemli 
M.H., Hadj Mohamed B., Sassi L., Darghouth M.A., 
Djaïem A.A., Bayoudh M. and Messadi L. (2014). 
First serological study of the prevalence of Anaplasma 
phagocytophilum in dromedary (Camelus dromedarius) 
in Tunisia. Bull. Soc. Pathol. Exot. 107:1-6.
Berzina I., Capligina V., Bormane A., Pavulina A., 
Baumanis V., Ranka R., Granta R. and Matise I. (2013). 
Association between Anaplasma phagocytophilum 
seroprevalence in dogs and distribution of Ixodes 
ricinus and Ixodes persulcatus ticks in Latvia. Ticks 
Tick Borne Dis. 4: 83-88.
Beugnet F. and Marié J.L. (2009). Emerging arthropod-
borne diseases of companion animals in Europe. Vet. 
Parasitol. 163: 298-305.
Bexfield N.H., Villiers E.J. and Herrtage M.E. (2005). Immune-
mediated haemolytic anaemia and thrombocytopenia 
associated with Anaplasma phagocytophilum in a dog. 
J. Small Anim. Pract. 46: 543-548.
Cao W.C., Zhan L., He J., Foley J.E., De Vlas S.J., 
Wu X.M., Yang H., Richardus J.H. and Habbema 
J.D. (2006). Natural Anaplasma phagocytophilum 
infection of ticks and rodents from a forest area of Jilin 
Province, China. Am. J. Trop. Med. Hyg. 75: 664-668.
Carrade D.D., Foley J.E., Borjesson D.L. and Sykes J.E. 
(2009). Canine granulocytic anaplasmosis: a review. 
J. Vet. Int. Med. 23: 1129-1141.
Centers for Disease Control and Prevention (CDC). (2008). 
Anaplasma phagocytophilum transmitted through 
blood transfusion: Minnesota, 2007. MMWR Morb. 
Mortal Wkly. Rep. 57: 1145-1148.
Cochez C., Ducoffre G., Vandenvelde C., Luyasu V. and 
Heyman P. (2011). Human anaplasmosis in Belgium: 
a 10-year seroepidemiological study. Ticks Tick Borne 
Dis. 2: 156-159.
Cockwill K.R., Taylor S.M., Snead E.C.R., Dickinson R., 
Cosford K., Malek S., Lindsay L.R. and Diniz P.P. 
(2009). Granulocytic anaplasmosis in three dogs from 
Saskatoon, Saskatchewan. Can. Vet. J. 50: 835-840.
Dahlgren F.S., Mandel E.J., Krebs J.W., Massung R.F. 
and McQuiston J.H. (2011). Increasing incidence of 
Ehrlichia chaffeensis and Anaplasma phagocytophilum 
in the United States, 2000–2007. Am. J. Trop. Med. 
Hyg. 85: 124-131.
Day M.J. (2011). One health: the importance of companion 
animal vector-borne diseases. Parasit. Vectors. 4: 49-54.
Diniz P.P. and Breitschwerdt E.B. (2012). Anaplasma 
phagocytophilum infection (canine granulocytic 
anaplasmosis) in Infectious Diseases of the Dog and 
Cat, Fourth Edition, edited by Greene CE., Elsevier, 
244-254.    
Doudier B., Olano J., Parola P. and Brouqui P. (2010). 
Factors contributing to emergence of Ehrlichia and 
Anaplasma spp. as human pathogens. Vet. Parasitol. 
167: 149-154.
Dumler J.S., Barbet A.F., Bekker C.P., Dasch G.A., 
Palmer G.H., Ray S.H., Rikihisa Y. and Rurangirwa 
F.R. (2001). Reorganization of genera in the families 
Rickettsiaceae and Anaplasmataceae in the order 
Rickettsiales: unification of some species of Ehrlichia 
with Anaplasma, Cowdria with Ehrlichia and Ehrlichia 
51Rev. Mar. Sci. Agron. Vét. (2015) 3 (2):43-52
with Neorickettsia, descriptions of six new species 
combinations and designation of Ehrlichia equi and 
- HGE agent’ as subjective synonyms of Ehrlichia 
phagocytophila. Int. J. Syst. Evol. Microbiol. 51: 2145-
2165.
Dumler J.S., Choi K.S., Garcia-Garcia J.C., Barat N.S., 
Scorpio D.G., Garyu J.W., Grab D.J. and Bakken 
J.S. (2005). Human granulocytic anaplasmosis and 
Anaplasma phagocytophilum. Emerg. Infect. Dis. 11: 
1828-1834. 
Dumler J.S., Madigan J.E., Pusterla N. and Bakken J.S. 
(2007). Ehrlichioses in humans: epidemiology, clinical 
presentation, diagnosis, and treatment. Clin. Infect. 
Dis. 45 (Suppl 1): S45-S51.
Dumler J.S. (2012). The biological basis of severe 
outcomes in Anaplasma phagocytophilum infection. 
Immunol. Med. Microbiol. 64: 13-20.
Eberts M.D., Diniz P.P., Beall M.J., Stillman B.A., 
Chandrashekar R. and Breitschwerdt E.B. (2011). 
Typical and atypical manifestations of Anaplasma 
phagocytophilum infection in dogs. J. Am. Anim. Hosp. 
Assoc. 47 (6): e88-e94.
Folkema A.M., Holman R.C., McQuiston J.H. and Cheek 
J.E (2012). Trends in Clinical Diagnoses of Rocky 
Mountain Spotted Fever among American Indians, 
2001–2008. Am. J.Trop. Med. Hyg. 86: 152-158.
Franzen P., Aspan A., Egenvall A., Gunnarsson A., 
Karlstam E. and Pringle J. (2009). Molecular evidence 
for persistence of Anaplasma phagocytophilum from 
acute experimental infection. J. Vet. Intern. Med. 23: 
636-642.
Ghafar M.W. and Amer S.A. (2012). Prevalence and 
first molecular characterization of Anaplasma 
phagocytophilum, the agent of human granulocytic 
anaplasmosis, in Rhipicephalus sanguineus ticks 
attached to dogs from Egypt. J. Adv. Res. 3: 189-194.
Gorna M., Adaszek L., Policht K., Skrzypczak M. and 
Winiarczyk S. (2013). Detection of Anaplasma 
phagocytophilum in a cat. Vet. Med-Czech. 58: 3 9-43.
Guyot H., Ramery E, O’Grady L., Sandersen C. and Rollin 
F. (2011). Emergence of bovine ehrlichiosis in Belgian 
cattle herds. Ticks Tick Borne Dis. 2: 116-118.
Heikkilä H.M., Bondarenko A., Mihalkov A., Pfister K. 
and Spillmann T. (2010). Anaplasma phagocytophilum 
infection in a domestic cat in Finland: case report. Acta 
Vet. Scand. 52: 62-67.
Heyman P., Cochez C., Hofhuis A., van der Giessen J., 
Sprong H., Porter S.R., Losson B., Saegerman C., 
Donoso-Mantke O., Niedrig M. and Papa A. (2010). 
A clear and present danger: tick-borne diseases in 
Europe. Expert Rev. Anti. Infect. Ther. 8: 33-50.
Jin H., Wei F., Liu Q. and Qian J. (2012). Epidemiology 
and control of human granulocytic anaplasmosis: a 
systematic review. Vector Borne Zoonotic Dis. 12: 
269-274.
Keesing F., McHenry D.J., Hersh M., Tibbetts M., Brunner 
J.L., Killilea M., LoGiudice K., Schmidt K.A. and 
Ostfeld R.S. (2014). Prevalence of human-active and 
variant 1 strains of the tick-borne pathogen Anaplasma 
phagocytophilum in hosts and forests of Eastern North 
America. Am. J. Trop. Med. Hyg. 91: 302-309.
Kohn B., Galke D., Beelitz P. and Pfister K. (2008). 
Clinical features of canine granulocytic anaplasmosis 
in 18 naturally infected dogs. J. Vet. Intern. Med. 22: 
1289-1295.
Krämer K., Schaper R., Schunack B., Połozowski A., 
Piekarska J., Szwedko A., Jodies R., Kowalska D., 
Schüpbach D. and Pantchev N. (2014). Serological 
detection of Anaplasma phagocytophilum, Borrelia 
burgdorferi sensu lato and Ehrlichia canis antibodies 
and Dirofilaria immitis antigen in a countrywide survey 
in dogs in Poland. Parasitol. Res. 113: 3229-3239.
kybicova, K (2010). Borrelia burgdorferi sensu lato and 
Anaplasma phagocytophilum in the Czech Republic, 
PhD Thesis, Charles University in Prague.
Lappin M.R. and Breitschwerdt E.B. (2012). Anaplasma 
phagocytophilum infection (feline granulocytic 
anaplasmosis) in Infectious Diseases of the Dog 
and Cat, Fourth Edition, Chapter 26, Ehrlichia and 
Anaplasma Infections  p254-256.
Leiby D.A., Chung A.P.S., Cable R.G., Trouern-Trend J., 
McCullough J., Homer M.J., Reynolds L.D., Houghton 
R.L., Lodes M.J. and Persing D.H. (2002). Relationship 
between tick bites and the seroprevalence of Babesia 
microti and Anaplasma phagocytophila (previously 
Ehrlichia sp.) in blood donors. Transfusion 42: 1585-1591.
Li H., Zhou Y., Wang W., Guo D., Huang S. and Jie S. 
(2011). The clinical characteristics and outcomes of 
patients with human granulocytic anaplasmosis in 
China. Int. J. Infect. Dis. 15: 859-866.
Little SE. (2012). Ehrlichiosis and anaplasmosis in dogs 
and cats. Vet. Clin. North. Am. Small Anim. Pract. 40: 
1121-1140.
Littman M.P., Goldstein R.E., Labato M.A., Lappin M.R. 
and Moore G.E. (2006). ACVIM small animal consensus 
statement on Lyme disease in dogs: diagnosis, treatment, 
and prevention. J. Vet. Intern. Med. 20: 422-434.
Mazepa A.W., Kidd L.B., Young K.M. and Trepanier 
L. (2010). Clinical presentation of 26 Anaplasma 
phagocytophilum-seropositive dogs residing in an 
endemic area. J. Am. Anim. Hospl. Assoc. 46: 405-412.
Mentaberre G., Gutiérrez C., Rodríguez N.F., Joseph S., 
González-Barrio D., Cabezón O., de la Fuente J., 
Gortazar C. and Boadella M. (2013). A transversal 
study on antibodies against selected pathogens in 
dromedary camels in the Canary Islands, Spain. Vet. 
Microbiol. 167: 468-473.
M’ghirbi Y., Ghorbel A., Amouri M., Nebaoui A., Haddad 
S. and Bouattour A. (2009). Clinical, serological, and 
molecular evidence of ehrlichiosis and anaplasmosis in 
dogs in Tunisia. Parasitol. Res. 104: 767-774.
M’ghirbi Y., Yaïch H., Ghorbel A. and Bouattour A. (2012). 
Anaplasma phagocytophilum in horses and ticks in 
Tunisia. Parasit. Vectors 5: 180-186.
Michalik J., Stańczak J., Cieniuch S., Racewicz M. and Siko 
B. (2012).Wild Boars as Hosts of HumanPathogenic 
Anaplasma phagocytophilum Variants. Emerging 
Infectious Diseases 18: 998-1001.
Michelet L., Delannoy S., Devillers E., Umhang G., Aspan 
A., Juremalm M., Chirico J., van der Wal F.J., Sprong 
H., Boye Pihl T.P., Klitgaard K., Bødker R., Fach P. 
and Moutailler S. (2014). High-throughput screening 
of tick-borne pathogens in Europe. Front Cell Infect. 
Microbiol. 4: 1-13.
52 El Hamiani Khatat and Sahibi: Anaplasma phagocytophilum, an emerging but unrecognized tick-borne pathogen
Nicholson W.L., Allen K.E., McQuiston J.H., Breitschwerdt 
E.B and Little S.E. (2010). The increasing recognition 
of rickettsial pathogens in dogs and people. Trends 
Parasitol. 26: 205-212.
Nijhof A.M., Bodaan C., Postigo M., Nieuwenhuijs H., 
Opsteegh M., Franssen L., Jebbink F. and Jongejan F. 
(2007). Ticks and associated pathogens collected from 
domestic animals in the Netherlands. Vector Borne 
Zoonotic Dis. 7: 585-596.
Poitout F.M., Shinozaki J.K., Stockwell P.J.  Holland 
C.J. and Shukla S.K. (2005). Genetic variants of 
Anaplasma phagocytophilum infecting dogs in 
Western Washington State. J. Clin. Microbiol. 43: 
796-801.
Pruneau L., Moumène A., Meyer D.F., Marcelino I., 
Lefrançois T. and Vachiéry N. (2014). Understanding 
Anaplasmataceae pathogenesis using “Omics” 
approaches. Front Cell Infect. Microbiol. 4: 86-92.
Pusterla N.and Madigan J.E. (2013). Equine granulocytic 
anaplasmosis. J. Equine Vet. Sci. 33: 493-496.
Qablan M.A., Kubelová M ., Siroký P., Modrý D. and 
Amr Z.S. (2012). Stray dogs of northern Jordan as 
reservoirs of ticks and tick-borne hemopathogens. 
Parasitol. Res. 111: 301-307.
Qurollo A.B., Chandrashekar R., Hegarty B.C., Beall 
M.J., Stillman B.A., Liu J., Thatcher B., Pultorak E., 
Cerrito B., Walsh M. and Breitschwerdt E.B. (2014). 
A serological survey of tick-borne pathogens in dogs 
in North America and the Caribbean as assessed by 
Anaplasma phagocytophilum, A. platys, Ehrlichia 
canis, E. chaffeensis, E. ewingii, and Borrelia 
burgdorferi species-specific peptides. Infect. Ecol. 
Epidemiol.: 10.3402/iee.v4.24699.
Ravnik U, Bajuk B. P., Lusa L. and Tozon N. (2014). Serum 
protein profiles, circulating immune complexes and 
proteinuria in dogs naturally infected with Anaplasma 
phagocytophilum. Veterinary Microbiology 173: 160-
165.
Ravnik U., Tozon N., Strasek Smrdel K. and Avsic Zupanc 
T. (2011). Anaplasmosis in dogs: the relation of 
haematological, biochemical and clinical alterations 
to antibody titre and PCR confirmed infection. Vet. 
Microbiol. 149: 172-176.
Rizzoli A., Silaghi C., Obiegala A., Rudolf I., Hubálek Z., 
Földvári G., Plantard O., Vayssier-Taussat M., Bonnet 
S., Špitalská E. and Kazimírová M. (2014). Ixodes 
ricinus and its transmitted pathogens in urban and 
peri-urban areas in Europe: new hazards and relevance 
for public health. Front Public Health doi:10.3389/
fpubh.2014.00251. 
Rymaszewska A. and Adamska M. (2011). Molecular 
evidence of vector-borne pathogens coinfecting dogs 
from Poland. Acta Vet. Hung. 59: 215-223.
Sainz A., Roura X., Miró G., Estrada-Peña A., Kohn B., 
Harrus S. and Solano-Gallego L. (2015). Guideline 
for veterinary practitioners on canine ehrlichiosis and 
anaplasmosis in Europe. Parasit. Vectors 8: 75-94.
 Sarih M., M’Ghirbi Y., Bouattour A., Gern L., Baranton 
G. and Postic D. (2005). Detection and identification 
of Ehrlichia spp. in ticks collected in Tunisia and 
Morocco. J. Clin. Microbiol. 43: 1127-1132. 
Schreiber C., Krücken J., Beck S., Maaz D., Pachnicke 
S., Krieger K., Gross M., Kohn B. and von Samson-
Himmelstjerna G. (2014). Pathogens in ticks collected 
from dogs in Berlin/Brandenburg, Germany. Parasit. 
Vectors 7: 535-344.
Silaghi C., Kohn B., Chirek A., Thiel C., Nolte I., Liebisch 
G. and Pfister K. (2011). Relationship of molecular 
and clinical findings on Anaplasma phagocytophilum 
involved in natural infections of dogs. J. Clin. 
Microbiol. 49: 4413-4414.
Stanek G., Wormser G.P., Gray J. and Strle F. (2012). Lyme 
borreliosis. Lancet 379: 461-473.
Strašek Smrdel K., Loewenich F.D, Miroslav Petrovec 
M. and Avšič Županc T. (2015). Diversity of ankA 
and msp4 genes of Anaplasma phagocytophilum in 
Slovenia. Ticks and Tick-borne Diseases 6:164–166.
Stuen S., Granquist E.G. and Silaghi C. (2013). Anaplasma 
phagocytophilum—a widespread multi-host pathogen 
with highly adaptive strategies. Front Cell Infect. 
Microbiol. 3: 1-33.
Swanson S.J., Neitzel D., Reed K.D. and Belongia E.A. 
(2006). Coinfections acquired from Ixodes ticks. Clin. 
Microbiol. Rev. 19: 708-727. 
Villeneuve A., Goring J., Marcotte L. and Overvelde 
S. (2011). Seroprevalence of Borrelia burgdorferi, 
Anaplasma phagocytophilum, Ehrlichia canis, and 
Dirofilaria immitis among dogs in Canada. Can. Vet. 
J. 52: 527-530.
Weil A.A., Baron E.L., Brown C.M. and Drapkin M.S. 
(2012). Clinical findings and diagnosis in human 
granulocytic anaplasmosis: a case series from 
massachusetts. Mayo Clin. Proc. 87: 233-239. 
Woldehiwet Z. (2010). The natural history of Anaplasma 
phagocytophilum. Vet. Parasitol. 167: 108-122.
Yancey C.B., Hegarty B.C., Qurollo B.A., Levy M.G., 
Birkenheuer A.J., Weber D.J., Diniz P.P. and 
Breitschwerdt E.B. (2014). Regional seroreactivity 
and vector-borne disease eo-Exposures in dogs in 
the United States from 2004–2010: utility of canine 
surveillance. Vector Borne Zoonotic Dis. 14: 724-732.
Zhang L., Liu H., Xu B., Lu Q., Li L., Chang L., Zhang X., 
Fan D., Li D., Jin Y., Cui F., Shi Y., Li W., Xu J. and 
Yu X.J. (2012). Anaplasma phagocytophilum infection 
in domestic animals in ten provinces/cities of China. 
Am. J. Trop. Med. Hyg. 87: 185-189.
Zhang L, Liu Y, Ni D, Li Q, Yu Y, Yu XJ, et al. (2008). 
Nosocomial transmission of human granulocytic 
anaplasmosis in China. JAMA 300:2263–70.
